SARS-CoV-2 RNA in blood

This dataset provides supplementary material for a report of the prevalence of SARS-CoV-2 RNA in blood and blood products.<br><b>S1 Table: </b>Metadata table providing data for prevalence of SARS-CoV-2 RNA in blood and blood products based on a systematic literature review. Details of 28 citations are shown, and the 22 studies included in quantitative meta-analysis are indicated. <br> <b>S2 Table: </b>Metadata table providing underlying data for serum samples from adults with COVID-19 infection. Sheet 1: samples obtained through patients recruited into a UK clinical cohort at Oxford University Hospitals NHS Foundation Trust (n=212). Cells highlighted in blue show follow-up samples collected from the same individual at different time points. Cells highlighted in orange show serum PCR positives. Sheet 2: samples obtained from convalescent donors a minimum of 28 days post resolution of symptoms, via NHS Blood and Transfusion, NHSBT (n=212). <br> <b>S3 Methods: </b>Details of RT-PCR reagents and cycling conditions for detection of SARS CoV-2 RNA.<br> <b>S4 Methods and data:</b> qRT-PCR quantification of vRNA from sera and viral culture assays. File contains methods for qRT-PCR and calculation of vRNA copy numbers, and qRT-PCR results in figure and table format.<br><br>